Who
Glenn David
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Phibro Animal Health; Executive Vice President, Zoetis.
In numbers
- Trades disclosed
- 141
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $21.7M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Jul 2014
- Last trade
- 6 Aug 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 17 Sep 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,482 at $0.00 | filing |
| 6 Aug 2026filed 17 Sep 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,482 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,334 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,334 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $31K840 at $36.60 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $31K840 at $36.60 | filing |
| 11 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $647K12,528 at $51.63 | filing |
| 11 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $647K12,528 at $51.63 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | —30,000 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | —30,000 | filing |
| 15 Aug 2025filed 19 Aug 2025 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,845 at $0.00 | filing |
| 9 Feb 2025filed 11 Feb 2025 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 9 Feb 2025filed 11 Feb 2025 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | —30,000 | filing |
| 9 Feb 2024filed 9 Feb 2024 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 13 Jan 2023filed 18 Jan 2023 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,365163.96 at $51.02 | filing |
| 7 Oct 2022filed 11 Oct 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,760208.72 at $46.76 | filing |
| 15 Jul 2022filed 19 Jul 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,760178.16 at $54.78 | filing |
| 8 Apr 2022filed 12 Apr 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $44K707.56 at $62.20 | filing |
News
ZTS - Zoetis Inc Class A AnalysisZTS · morningstar.com · 12 Oct 2026
0 headlines in the last 90 days name Glenn David; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.